Are serum A-FABP concentrations associated with myocardial perfusion abnormalities, left ventricular function, and heart failure in patients with coronary artery disease?
Serum A-FABP levels may serve as a biomarker for myocardial perfusion abnormalities, left ventricular dysfunction, and heart failure in patients with coronary artery disease.
Serum A-FABP levels not only were associated with myocardial perfusion abnormalities and left ventricular function, but also predicted the presence of heart failure in our patients with CAD.
Huang et al. (Wed,) studied this question.